Zhang, Chenting
Zhong, Bihua
Jiang, Qian
Lu, Wenju
Wu, Hongkai
Xing, Yue
Wu, Xuefen
Zhang, Zizhou
Zheng, Yulin
Li, Peiwen
Li, Zhenxiang
Lin, Ziying
Chen, Yuqin
Hong, Cheng
Zhao, Zhuxiang
Zhang, Tingting
Liang, Weiquan
Zhang, Yi
Zhang, Caojin
Yuan, Jason X.-J.
Liu, Chunli
Wang, Jian
Yang, Kai
Funding for this research was provided by:
National Natural Science Foundation of China (82241012, 82270052, 82120108001, 82170065, 82170069, 82370063, 82241012, 82270052, 82120108001, 82170065, 82170069, 82370063, 82241012, 82270052, 82120108001, 82170065, 82170069, 82370063, 82241012, 82270052, 82120108001, 82170065, 82170069, 82370063)
National Science and Technology Innovation 2030, Major Project- Research on Cancer, Cardiovascular, Respiratory and Metabolic Diseases (2024ZD0528700)
Article History
Received: 18 August 2024
Accepted: 3 March 2025
First Online: 10 March 2025
Declarations
:
: This study conforms to the principles outlined in the Declaration of Helsinki and was approved by the ethics committee of all participating hospitals and institutions, including the First Affiliated Hospital of Guangzhou Medical University (Ethical approval numbers: 2020–04), the Second Affiliated Hospital of Guangzhou Medical University (Ethical approval numbers: 2019–05-ks-04), Guangdong Provincial People’s Hospital (Ethical approval numbers: GDREC2015254H(R1)), Guangzhou First People’s Hospital (Ethical approval numbers: K-2022–083-02), and the Second People’s Hospital of Foshan (Ethical approval numbers: 2022–0145). All subjects obtained and signed broad informed consents before enrollment.
: Not applicable.
: The authors declare no competing interests.